

Apple CFO Steps Down, Bronfman Drops Paramount Bid, Lilly’s New Form of Zepbound 8/27/24
Aug 27, 2024
In this discussion, Luca Maestri, Apple's longtime CFO, shares insights ahead of his departure, focusing on the upcoming iPhone event and the implications for corporate finance strategies. Edgar Bronfman Jr. reveals the challenges faced in his recent bid for Paramount, further influencing media investments. The conversation touches on Eli Lilly's strategic move to lower the cost of its weight loss drug, aiming to increase access while navigating supply constraints. Together, they explore the intersection of tech, finance, and media.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10
Intro
00:00 • 3min
Market Dynamics and AI Innovations
03:09 • 5min
Apple's CFO Departure and Strategic Buyback Insights
08:01 • 2min
The Influence and Tenure of CFOs in Major Companies
10:05 • 2min
Key Financial Movements and the Impact of AI on Industry
12:21 • 2min
Edgar Bronfman's Paramount Bid Withdrawal
14:03 • 4min
The Decline of Linear Cable and the Shift to Streaming
18:31 • 2min
Market Movers: Lululemon and Coca-Cola Insights
20:50 • 7min
Market Insights: Pharmaceuticals to Tech
28:20 • 16min
Valuations and Investment Strategies in Sports Teams
43:52 • 2min